Tumefactive multiple sclerosis and fingolimod

被引：0
|
作者：
Lovera, Jesus [1 ]
Villemarette-Pittman, Nicole [1 ]
机构：
[1] Louisiana State Univ, Hlth Sci Ctr New Orleans, Dept Neurol, New Orleans, LA 70112 USA
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2014年 / 344卷 / 1-2期
关键词：
NATALIZUMAB TREATMENT; DISEASE-ACTIVITY; LESIONS; INTERRUPTION; THERAPY;
D O I：
10.1016/j.jns.2014.06.022
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [1] TUMEFACTIVE REBOUND OF MULTIPLE SCLEROSIS FOLLOWING CESSATION OF FINGOLIMOD
    Salam, Sharfaraz
    Dunbar, Daniel
    Lavin, Tim
    Pace, Adrian
    Mihalova, Tatiana
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [2] TUMEFACTIVE MULTIPLE SCLEROSIS LESIONS UNDER FINGOLIMOD TREATMENT
    Visser, Femke
    Wattjes, Mike P.
    Pouwels, Petra J. W.
    Linssen, Wim H. J. P.
    van Oosten, Bob W.
    NEUROLOGY, 2012, 79 (19) : 2000 - 2002
  • [3] Tumefactive multiple sclerosis and fingolimod Immunotherapies and unintended consequences
    Paul, Friedemann
    Bourdette, Dennis
    NEUROLOGY, 2013, 81 (19) : 1648 - 1649
  • [4] Tumefactive multiple sclerosis in association with fingolimod initiation and discontinuation
    Croteau, David
    Tobenkin, Anne
    Brinker, Allen
    Kortepeter, Cindy M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (06) : 903 - 912
  • [5] Tumefactive multiple sclerosis lesions associated with fingolimod treatment
    Sanchez, P.
    Meca-Lallana, V.
    Aguirre, C.
    Dotor, J.
    Vivancos, J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 1020 - 1021
  • [6] TUMEFACTIVE MULTIPLE SCLEROSIS LESIONS UNDER FINGOLIMOD TREATMENT Response
    Wattjes, Mike P.
    Visser, Femke
    van Oosten, Bob W.
    NEUROLOGY, 2013, 81 (04) : 403 - 403
  • [7] Tumefactive multiple sclerosis lesions associated with fingolimod treatment: Report of 5 cases
    Sanchez, Pedro
    Meca-Lallana, Virginia
    Vivancos, Jose
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 25 : 95 - 98
  • [8] Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod
    Jander, Sebastian
    Turowski, Bernd
    Kieseier, Bernd C.
    Hartung, Hans-Peter
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (11) : 1650 - 1652
  • [9] Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatment
    Faissner, Simon
    Hoepner, Robert
    Lukas, Carsten
    Chan, Andrew
    Gold, Ralf
    Ellrichmann, Gisa
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (05) : 233 - 238
  • [10] Tumefactive demyelinating lesions after initiating fingolimod in patient with multiple sclerosis: A case report
    Navardi, S.
    Sahraian, M. A.
    Moghadasi, A. Naser
    REVUE NEUROLOGIQUE, 2020, 176 (04) : 289 - 290
12345